Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
51.6M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
2.73M
-
Shares change
-
-397K
-
Total reported value, excl. options
-
$11.2M
-
Value change
-
-$1.72M
-
Put/Call ratio
-
1.07
-
Number of buys
-
13
-
Number of sells
-
-15
-
Price
-
$4.12
Significant Holders of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) as of Q4 2023
41 filings reported holding ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share as of Q4 2023.
ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.73M shares
of 51.6M outstanding shares and own 5.29% of the company stock.
Largest 10 shareholders include Shay Capital LLC (725K shares), VANGUARD GROUP INC (606K shares), Long Focus Capital Management, LLC (248K shares), GEODE CAPITAL MANAGEMENT, LLC (185K shares), LPL Financial LLC (179K shares), RAYMOND JAMES & ASSOCIATES (155K shares), NORTHERN TRUST CORP (102K shares), Walleye Capital LLC (82.6K shares), WELLS FARGO & COMPANY/MN (69.9K shares), and J. Goldman & Co LP (67.5K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.